ARCHIVES

New Drug Reduces Nausea and Vomiting

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990

NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion

June 9, 1978

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003